IMAC Holdings, Inc.

Equities

BACK

US44967K3023

Healthcare Facilities & Services

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
3.92 ^USD	-23.14%		+26.86%	+77.38%

Apr. 16	IMAC Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Apr. 10	IMAC Holdings, Inc. announced that it expects to receive $0.9 million in funding from District 2 Capital LP, Ashton Capital Corporation, Cavalry Fund I Management, LLC, Kips Bay Select LP, Walleye Capital LLC, Lincoln Park Capital, LLC	CI

IMAC HOLDINGS, INC. : Other Events (form 8-K)

September 08, 2020 at 09:36 am EDT

Item 8.01. Other Events.

On September 4, 2020, IMAC Holdings, Inc. (the "Company") and Edward S. Bredniak agreed to extend the maturity date of the outstanding 10.00% Promissory Note, for the principal amount of $1,750,000 (the "Note") due to Mr. Bredniak, to January 5, 2022. The Note was previously due January 5, 2021.

Latest news about IMAC Holdings, Inc.

IMAC Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 16	CI
IMAC Holdings, Inc. announced that it expects to receive $0.9 million in funding from District 2 Capital LP, Ashton Capital Corporation, Cavalry Fund I Management, LLC, Kips Bay Select LP, Walleye Capital LLC, Lincoln Park Capital, LLC	Apr. 09	CI
Top Premarket Decliners	Dec. 28	MT
IPM Medical Group, Inc. acquired IMAC Regeneration Center in Arlington Heights, Illinois from IMAC Holdings, Inc..	Dec. 11	CI
IMAC Holdings, Inc. Announces Executive Changes	Nov. 30	CI
The Regenerative Center, LLC acquired Tangible and intangible assets of Kentucky operation of IMAC Holdings, Inc. for $0.08 million.	Nov. 29	CI
IMAC Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 21	CI
IMAC Holdings Regains Compliance With Nasdaq Listing Rule	23-09-28	MT
Labor Data, Inflation Woes Weigh on Exchange-Traded Funds, Equity Futures Premarket Friday	23-09-08	MT
IMAC Holdings Implements 1-for-30 Reverse Stock Split	23-09-08	MT
IMAC Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-21	CI
IMAC Holdings, Inc. announced that it has received $4.3 million in funding from Theralink Technologies, Inc. and other investors	23-07-25	CI
IMAC, Theralink Technologies Sign Merger Deal; IMAC Shares Jump	23-05-23	MT
IMAC Holdings, Inc. Appoints Jeffrey Busch to Serve as Chairman	23-05-23	CI
IMAC Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-19	CI
Theralink Technologies, Inc. entered into a definitive agreement and plan of merger to acquire IMAC Holdings, Inc. for $0.9 million in a reverse merger transaction.	23-05-14	CI
Brain Scientific Inc. cancelled the acquisition of IMAC Holdings, Inc..	23-04-30	CI
IMAC Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-31	CI
IMAC Holdings, Inc. Auditor Raises 'Going Concern' Doubt	23-03-30	CI
IMAC Holdings Signs Binding Letter of Intent to Merge with Brain Scientific	23-03-20	MT
Brain Scientific Inc. executed a Letter of Intent to acquire IMAC Holdings, Inc..	23-03-19	CI
IMAC Holdings, Inc. Announces Resignation of Ben Lerner as Chief Operating Officer	23-03-01	CI
Top Premarket Gainers	23-03-01	MT
Curis Functional Health, LLC. acquired The Back Space, LLC from IMAC Holdings, Inc..	23-02-28	CI
Earnings Flash (BACK) IMAC HOLDINGS Posts Q3 Revenue $3.8M	22-11-15	MT

Chart IMAC Holdings, Inc.

Duration

Period

More charts

Company Profile

IMAC Holdings, Inc. owns and manages health and wellness centers that delivers sports medicine, orthopedic care, and restorative joint and tissue therapies for movement restricting pain and neurodegenerative diseases. The Company provides movement, orthopedic and neurological therapies through its chain of Innovative Medical Advancements and Care (IMAC) Regeneration Centers. The Company, through its outpatient medical clinics, provide conservative, minimally invasive medical treatments to help patients with back pain, knee pain, joint pain, ligament and tendon damage, and other related soft tissue conditions. It operates through two business segments: outpatient medical centers and clinical research division. The Company's research division is conducting a Phase I clinical trial evaluating a mesenchymal stem cell therapy candidate for bradykinesia due to Parkinsonâs disease. The Company operates approximately 10 outpatient medical clinics in five states in the United States.

Sector

Healthcare Facilities & Services

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

5.1 USD

Average target price

8 USD

Spread / Average Target

+56.86%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Hospitals, Clinics & Primary Care Services

	1st Jan change	Capi.
IMAC HOLDINGS, INC.	+77.38%	5.86M
AIER EYE HOSPITAL GROUP CO., LTD.	-20.16%	15.76B
BANGKOK DUSIT MEDICAL SERVICES	+4.50%	12.34B
IHH HEALTHCARE	+3.98%	11.52B
APOLLO HOSPITALS ENTERPRISE LIMITED	+9.72%	11.02B
ENCOMPASS HEALTH CORPORATION	+23.61%	8.28B
RAMSAY HEALTH CARE LIMITED	-2.19%	7.8B
MOUWASAT MEDICAL SERVICES COMPANY	+20.75%	7.2B
THE ENSIGN GROUP, INC.	+4.49%	6.67B
GLOBAL HEALTH LIMITED	+50.89%	4.64B

Hospitals, Clinics & Primary Care Services